Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges

Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges

Toshio Fujino, Kenichi Suda, Tetsuya Mitsudomi Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, JapanCorrespondence: Tetsuya MitsudomiKindai University Faculty of Medicine, Division of Thoracic Surgery, Department of Surgery, 377-2 Ohno-Higash...

Full description

Bibliographic Details
Main Authors: Fujino T, Suda K, Mitsudomi T
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Lung Cancer: Targets and Therapy
Subjects:
non-small cell lung cancer
met exon 14 skipping
capmatinib
tepotinib
resistance mechanisms
immune checkpoint inhibitors
Online Access:https://www.dovepress.com/lung-cancer-with-met-exon-14-skipping-mutation-genetic-feature-current-peer-reviewed-fulltext-article-LCTT

Internet

https://www.dovepress.com/lung-cancer-with-met-exon-14-skipping-mutation-genetic-feature-current-peer-reviewed-fulltext-article-LCTT

Similar Items